CAS 42252-34-6

Chemistry, 1 End Use API, 8 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

MARKET PLACE

1 Intermediates

1 Intermediates

Also known as: 42252-34-6, Ethylmethyl-carbamic chloride, Ethyl(methyl)carbamic chloride, N-ethyl-n-methylcarbamoylchloride, Ethylmethyl-carbamicchloride, N-ethyl-n-methyl carbamoyl chloride

Molecular Formula

C₄H₈ClNO

Molecular Weight

121.56 g/mol

InChI Key

XZVYDRLPXWFRIS-UHFFFAOYSA-N

1 2D Structure

CAS 42252-34-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-ethyl-N-methylcarbamoyl chloride

2.1.2 InChI

InChI=1S/C4H8ClNO/c1-3-6(2)4(5)7/h3H2,1-2H3

2.1.3 InChI Key

XZVYDRLPXWFRIS-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCN(C)C(=O)Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 42252-34-6

2. Ethylmethyl-carbamic Chloride

3. Ethyl(methyl)carbamic Chloride

4. N-ethyl-n-methylcarbamoylchloride

5. Ethylmethyl-carbamicchloride

6. N-ethyl-n-methyl Carbamoyl Chloride

7. N-ethyl-n-methyl Carbamoylchloride

8. N-ethyl-n-methylcarbamonyl Chloride

9. N-ethyl-n-methyl-carbamoyl Chloride

10. Carbamic Chloride, Ethylmethyl-

11. Ethylmethylcarbamic Chloride

12. Ethyl Methylcarbamic Chloride

13. Ethylmethyl Carbamyl Chloride

14. Schembl414542

15. Ethyl(methyl)carbamoyl Chloride

16. Dtxsid60459696

17. Act08763

18. Bcp27350

19. Mfcd08061404

20. Zinc21992762

21. Akos006285962

22. Mb05193

23. N-ethyl-n-methylcarbamoyl Chloride+b31

24. As-12359

25. Db-013277

26. Am20090787

27. Carbamic Chloride, N-ethyl-n-methyl-

28. Cs-0198150

29. E0963

30. Ft-0649367

31. F20387

32. 252e346

33. Q-101326

2.3 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₄H₈ClNO
Molecular Weight	121.56 g/mol
XLogP3	1.2
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	1
Rotatable Bond Count	1
Exact Mass	121.0294416 g/mol
Monoisotopic Mass	121.0294416 g/mol
Topological Polar Surface Area	20.3 Å²
Heavy Atom Count	7
Formal Charge	0
Complexity	74.1
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

N-Ethyl-N-Methyl Carbamoyl Chloride

PDF Supplier PDF

URL Supplier Web Content

CAS Number

42252-34-6

End Use API

Rivastigmine Tartrate

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US